Palisade Bio Inc (PALI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,144 | 2,352 | 4,196 | 6,142 | 8,546 |
| Receivables | 234 | 234 | N/A | N/A | N/A |
| Other current assets | 0 | 0 | 0 | 6 | 0 |
| TOTAL | $5,783 | $3,017 | $4,849 | $6,449 | $8,739 |
| Non-Current Assets | |||||
| PPE Net | 266 | 292 | 312 | 336 | 232 |
| Intangibles | 722 | 702 | 658 | 567 | 537 |
| Other Non-Current Assets | 75 | 75 | 69 | 69 | 202 |
| TOTAL | $1,063 | $1,069 | $1,039 | $971 | $971 |
| Total Assets | $6,846 | $4,086 | $5,889 | $7,420 | $9,710 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,655 | 1,844 | 1,394 | 773 | 811 |
| Accrued Expenses | 658 | 583 | 540 | 381 | 223 |
| TOTAL | $2,312 | $2,426 | $1,986 | $1,154 | $1,034 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 53 | N/A | N/A |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,312 | $2,426 | $1,986 | $1,154 | $1,034 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 54,095 | 53,882 | 48,682 | 48,486 | 48,486 |
| Common Shares | 541 | 487 | 487 | 485 | 484 |
| Retained earnings | -100,925 | -98,473 | -95,916 | -92,705 | -89,056 |
| TOTAL | $4,534 | $1,660 | $3,902 | $6,266 | $8,676 |
| Total Liabilities And Equity | $6,846 | $4,086 | $5,889 | $7,420 | $9,710 |